Complex regional pain syndrome (CRPS) is uncommon but not as rare as many people assume. Depending on which study you look at, somewhere between 5 and 26 new cases per 100,000 people are diagnosed each year. That puts it in a gray zone: the NIH’s Genetic and Rare Diseases Information Center does list CRPS, yet its incidence is higher than many conditions that carry the “rare disease” label. In practical terms, CRPS is rare enough that many doctors encounter it infrequently, which contributes to delayed and missed diagnoses.
How Common CRPS Actually Is
The most-cited population study, conducted in the Netherlands, found an overall incidence of 26.2 cases per 100,000 people per year. An earlier study from Olmsted County, Minnesota, using slightly different diagnostic criteria, reported a lower rate of about 5.5 per 100,000 per year for CRPS Type I and 0.82 per 100,000 for Type II. The gap between these numbers largely reflects differences in how the condition was defined and identified, not a true difference in how often it occurs.
For context, a condition is officially “rare” in the United States when it affects fewer than 200,000 people at any given time. CRPS likely falls near or just below that threshold in the U.S. population, depending on how many cases are active at once versus resolved. The period prevalence from the Minnesota data was about 20.6 per 100,000 for Type I, which would translate to roughly 68,000 Americans at any point in time. The Dutch incidence figures, applied to the U.S. population, suggest a considerably higher number. Either way, CRPS occupies an awkward space: common enough that emergency rooms and orthopedic clinics should recognize it, yet rare enough that many don’t.
Type I vs. Type II
CRPS comes in two forms. Type I, previously called reflex sympathetic dystrophy, develops without confirmed nerve damage and accounts for the vast majority of cases, roughly 26.2 per 100,000 per year. Type II, once known as causalgia, follows a verified nerve injury and is significantly less common at about 5.5 per 100,000 per year. Both types produce the same constellation of pain, swelling, and skin changes, so the distinction matters more for classification than for the patient’s day-to-day experience.
Who Gets CRPS
Most large studies find that women develop CRPS two to four times more often than men, though at least one Korean study found a nearly equal ratio. The condition can appear at any age. In women, it peaks in the 40s and 50s. In men, cases cluster in the 20s and again around the 40s. Children and teenagers can also develop CRPS, though exact pediatric prevalence is unknown because the condition is frequently missed in younger patients.
The most common trigger is a fracture, responsible for about 42% of cases in a large analysis of over 1,000 patients. Blunt injuries like sprains account for another 21%, surgery for 12%, and carpal tunnel syndrome for 7%. About 7% of people develop CRPS with no identifiable triggering event at all. The severity of the original injury doesn’t predict whether CRPS will follow. A minor sprain can set it off just as easily as a major fracture.
Why It’s Often Missed
There is no single blood test or imaging scan that confirms CRPS. Diagnosis relies on a clinical checklist known as the Budapest Criteria, which requires continuous pain that seems out of proportion to the original injury, plus a specific pattern of symptoms across four categories: heightened pain sensitivity, temperature or color changes in the skin, swelling or sweating abnormalities, and movement problems or changes to hair, nails, or skin texture. You need to report at least one symptom in all four categories and show visible signs in at least two during a clinical exam.
Because these symptoms overlap with normal post-injury inflammation, infections, blood clots, and other conditions, CRPS can be mistaken for something else entirely, especially in the early weeks. Doctors who rarely encounter CRPS may attribute the disproportionate pain to anxiety, poor healing, or simply not recognize the pattern. This diagnostic difficulty is one reason prevalence estimates vary so widely between studies. Some cases are never counted because they’re never correctly identified.
Recovery and Long-Term Outlook
Early studies painted an optimistic picture, suggesting most people recovered fully within a year. More recent research tells a more nuanced story: pain and disability do improve over time for many people, but most adults still have some degree of symptoms after the one-year mark. The earlier treatment begins, particularly physical therapy to maintain movement in the affected limb, the better the outcome tends to be.
Children have a notably better prognosis. CRPS in young patients typically improves within six to eight months, and complete recovery is common with early intervention. Some children do experience recurrences that require restarting therapy, and in a smaller number of cases, symptoms persist into adulthood. Among adults, younger and healthier individuals with good circulation tend to fare better than those diagnosed later or with other health complications.
Rare Enough to Be Overlooked
The practical answer to “is CRPS rare?” is that it’s uncommon enough to create real problems for the people who have it. Primary care doctors may go years between cases. Patients often describe a long, frustrating path to diagnosis, bouncing between specialists who each rule out their own area of expertise before someone considers CRPS. The condition’s rarity also means fewer treatment centers specialize in it, fewer clinical trials recruit for it, and public awareness remains low compared to other chronic pain conditions. If you’re dealing with persistent, disproportionate pain after an injury along with visible skin changes, swelling, or temperature differences in the affected limb, those are the hallmarks worth bringing to a specialist’s attention.